Free Trial

New Vernon Investment Management LLC Increases Position in MetLife, Inc. $MET

MetLife logo with Finance background

Key Points

  • New Vernon Investment Management LLC increased its stake in MetLife, Inc. by 632.6%, owning 29,613 shares valued at approximately $2.38 million, making it the firm's 12th largest position.
  • MetLife reported a Q2 EPS of $2.02, missing analysts' expectations of $2.32, with a revenue of $17.34 billion, down 2.7% from the previous year.
  • The company declared a quarterly dividend of $0.5675 per share, which represents an annualized dividend yield of 2.8% and a payout ratio of 38.47%.
  • Five stocks to consider instead of MetLife.

New Vernon Investment Management LLC boosted its position in shares of MetLife, Inc. (NYSE:MET - Free Report) by 632.6% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 29,613 shares of the financial services provider's stock after acquiring an additional 25,571 shares during the period. MetLife comprises 3.2% of New Vernon Investment Management LLC's investment portfolio, making the stock its 12th biggest holding. New Vernon Investment Management LLC's holdings in MetLife were worth $2,378,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Ball & Co Wealth Management Inc. acquired a new position in MetLife during the 4th quarter worth approximately $25,000. North Capital Inc. acquired a new position in shares of MetLife in the 1st quarter valued at $26,000. Quarry LP acquired a new position in shares of MetLife in the 4th quarter valued at $31,000. Motco boosted its holdings in shares of MetLife by 105.5% in the 1st quarter. Motco now owns 413 shares of the financial services provider's stock valued at $33,000 after buying an additional 212 shares in the last quarter. Finally, WPG Advisers LLC acquired a new position in shares of MetLife in the 1st quarter valued at $46,000. Institutional investors and hedge funds own 94.99% of the company's stock.

MetLife Stock Performance

MetLife stock traded down $0.78 during trading hours on Tuesday, reaching $80.58. 3,836,445 shares of the stock were exchanged, compared to its average volume of 3,380,199. The stock has a market cap of $53.59 billion, a P/E ratio of 13.66, a P/E/G ratio of 0.73 and a beta of 0.87. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a 52-week low of $65.21 and a 52-week high of $89.05. The firm's 50 day moving average is $78.20 and its 200 day moving average is $78.38.

MetLife (NYSE:MET - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing analysts' consensus estimates of $2.32 by ($0.30). The firm had revenue of $17.34 billion for the quarter, compared to analysts' expectations of $18.58 billion. MetLife had a return on equity of 19.88% and a net margin of 5.83%.The firm's quarterly revenue was down 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.28 EPS. Analysts predict that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 9th. Stockholders of record on Tuesday, August 5th will be issued a $0.5675 dividend. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Tuesday, August 5th. MetLife's dividend payout ratio (DPR) is currently 38.47%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on MET shares. Wells Fargo & Company restated an "overweight" rating and issued a $97.00 target price (up previously from $94.00) on shares of MetLife in a report on Thursday, July 10th. JPMorgan Chase & Co. increased their price target on shares of MetLife from $86.00 to $95.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 8th. Jefferies Financial Group increased their price target on shares of MetLife from $100.00 to $103.00 and gave the stock a "buy" rating in a research note on Monday, August 11th. Wall Street Zen cut shares of MetLife from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Keefe, Bruyette & Woods decreased their price target on shares of MetLife from $94.00 to $92.00 and set an "outperform" rating for the company in a research note on Monday, August 11th. Ten equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $95.60.

Check Out Our Latest Analysis on MetLife

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines